Aptima Candida
Device
Gen-Probe, Inc.
Total Payments
$36,942
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $36,942 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $36,942 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Performance Evaluation of the Candida vaginitis and Trichomonas vaginalis tests on the Panther system | Gen-Probe, Inc. | $36,942 | 0 |
Top Doctors Receiving Payments for Aptima Candida
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Galveston, TX | $36,942 | 3 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $36,942
Product Information
- Type Device
- Total Payments $36,942
- Total Doctors 0
- Transactions 3
About Aptima Candida
Aptima Candida is a device associated with $36,942 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2018 to 2018. In 2018, $36,942 was paid across 3 transactions to 0 doctors.
The most common payment nature for Aptima Candida is "Unspecified" ($36,942, 100.0% of total).
Aptima Candida is associated with 1 research study, including "Performance Evaluation of the Candida vaginitis and Trichomonas vaginalis tests on the Panther system" ($36,942).